Al Nahdi Medical Company SCJSC
SAU:4164
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
SA |
|
Y
|
Yum! Brands Inc
F:TGR
|
US |
|
B
|
Balchem Corp
F:BL9B
|
US |
|
H
|
Hikari Tsushin Inc
XBER:HIK
|
JP |
|
P
|
PetroChina Co Ltd
XBER:PC6
|
CN |
|
Erlebnis Akademie AG
XETRA:EAD
|
DE |
|
F
|
Forvia SE
SWB:FAU
|
FR |
|
C
|
Crest Nicholson Holdings PLC
F:C38
|
UK |
|
W
|
Wells Fargo & Co
XETRA:NWT
|
US |
|
E
|
EverCommerce Inc
NASDAQ:EVCM
|
US |
|
Arlo Technologies Inc
NYSE:ARLO
|
US |
|
S
|
Synaptics Inc
XBER:SJN
|
US |
|
T
|
Terna Rete Elettrica Nazionale SpA
OTC:TEZNY
|
IT |
|
T
|
Terna Rete Elettrica Nazionale SpA
XMUN:UEI
|
IT |
|
A
|
Ageas SA
MIL:AGS
|
BE |
|
T
|
Telefonaktiebolaget LM Ericsson
F:ERCG
|
SE |
|
Synaptics Inc
NASDAQ:SYNA
|
US |
Wall St Price Targets
Price Targets Summary
Al Nahdi Medical Company SCJSC
According to Wall Street analysts, the average 1-year price target for Al Nahdi Medical Company SCJSC is 128.03 SAR with a low forecast of 106.2 SAR and a high forecast of 149.1 SAR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Al Nahdi Medical Company SCJSC's stock price target?
Price Target
128.03
SAR
According to Wall Street analysts, the average 1-year price target for Al Nahdi Medical Company SCJSC is 128.03 SAR with a low forecast of 106.2 SAR and a high forecast of 149.1 SAR.
What is the Revenue forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
8%
Over the last 7 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 4 years is 8%.
What is the Gross Profit forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
8%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 4 years is 8%.
What is the Operating Income forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
8%
Over the last 7 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 4 years is 8%.
What is the Pre-Tax Income forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
9%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
7%
Over the last 7 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 4 years is 7%.
